VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: The Nuclear-Chip IPO Pipeline Nobody's Pricing In
Value Add VC/Pulse/IPO

The Nuclear-Chip IPO Pipeline Nobody's Pricing In

Valar Atomics at a $6B private valuation and OLIX at $3.3B are both explicitly infrastructure bets, not software -- and neither has a clear public comp set yet, which means whoever lists first effectively prices the entire category.

By the Numbers

$6B private
Valar Atomics
$3.3B private
OLIX
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
August 4, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Valar Atomics ($6B) and OLIX ($3.3B) both raised large private rounds this week on infrastructure theses -- nuclear power and photonic chips -- with essentially no direct public comps

2

Existing public nuclear names (utilities, uranium producers) and chip names (Nvidia, AMD, Cerebras) don't cleanly map to either company's specific business model

3

That comp vacuum means whichever of these infrastructure-AI categories produces the first IPO effectively sets the valuation framework the rest of the category gets priced against

4

Both categories require multi-year capital before any commercial product ships, making them a genuinely different underwriting exercise than most AI application IPOs

TC

The VC Read · Trace's Take

Trace Cohen

This is the category I'd tell a growth-stage LP to actually study right now, not because either company is IPO-ready, but because whoever prices first here writes the rulebook everyone else in physical AI infrastructure gets valued against for years. Get comfortable with nuclear-plant and semiconductor-fab underwriting now, because it's coming into venture portfolios whether traditional software LPs are ready for it or not.

Tech IPO Tracker →Nuclear Energy Startups →

Analysis

Two of this week's largest private rounds -- Valar Atomics at a $6 billion valuation building factory-produced nuclear microreactors, and OLIX at $3.3 billion building photonic AI inference chips -- share a structural problem neither company has to solve today but will eventually: there's no clean public comp set for either business model.

No Clean Public Comps

Existing public nuclear names are utilities and uranium producers, not factory-manufactured microreactor developers selling directly to data center operators. Existing public chip names -- Nvidia, AMD, and now Cerebras -- are built around GPU architectures and HBM-based memory, not the SRAM-based approach OLIX is betting will bypass that exact supply constraint. Public investors pricing either company at IPO will be doing genuinely novel valuation work, not applying an existing multiple to a new logo.

“Public investors pricing either company at IPO will be doing genuinely novel valuation work, not applying an existing multiple to a new logo.”

That comp vacuum matters because whichever of these two adjacent categories -- AI-driven nuclear power, or non-GPU AI chip architectures -- produces the first real IPO will effectively set the valuation framework the rest of the category gets measured against, the same dynamic playing out right now between Anthropic and OpenAI on the AI-lab side.

Both categories also require a genuinely different kind of investor patience than most AI application IPOs. Neither Valar nor OLIX will ship a commercial product for one to two more years at minimum, meaning any IPO conversation for either company remains purely theoretical for now -- but the capital intensity of both businesses means an eventual public listing, to fund the next stage of manufacturing scale-up, is a more likely outcome than a pure M&A exit.

What to watch: whether either company signals IPO intent within the next 12-18 months as manufacturing milestones firm up, and whether public investors show any early appetite for infrastructure-AI stories without an existing comp set to lean on.

ShareXLinkedInEmail

Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 4, 2026

The Anthropic-OpenAI IPO Race, Scored

Illustration for: The Anthropic-OpenAI IPO Race, Scored
IPO

The Anthropic-OpenAI IPO Race, Scored

Anthropic confidentially filed for IPO first, at a $965B valuation on a $47B revenue run rate -- but OpenAI's IPO pipeline is also active, and the two companies are now effectively racing to define what an AI-lab public listing should look like.

IPO· Aug 4, 2026

Tech's Biotech IPO Window Is Quietly Reopening

Illustration for: Tech's Biotech IPO Window Is Quietly Reopening
IPO

Tech's Biotech IPO Window Is Quietly Reopening

While tech IPOs grab headlines, this week's actual new listings are almost entirely biotech -- a sign the broader IPO window is widening beyond the handful of AI mega-caps everyone's watching.

IPO· Aug 4, 2026

Cerebras, Three Months Public: The Scorecard

Illustration for: Cerebras, Three Months Public: The Scorecard
IPO

Cerebras, Three Months Public: The Scorecard

Cerebras went public in May at a $56.43B implied valuation, becoming the market's clearest test case for whether a pure-play AI chip challenger to Nvidia can hold a premium multiple once quarterly numbers replace private-market narrative.

@Trace_Cohen·t@nyvp.com